Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lara Lacerda

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Plos One|September 10, 2013
The antihelmintic drug pyrvinium pamoate targets aggressive breast cancerWei Xu, Lara Lacerda, Bisrat G Debeb, et al.
Breast Cancer Research and Treatment|November 23, 2015
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3aAdam R Wolfe, Bisrat G Debeb, Lara Lacerda, et al.
Molecular Cancer|July 10, 2010
Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cellsBisrat G Debeb, Xiaomei Zhang, Savitri Krishnamurthy, et al.
Plos One|September 3, 2010
Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cellsAnn H Klopp, Lara Lacerda, Anshul Gupta, et al.
Clinical Lung Cancer|October 22, 2018
Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC)Yasir Y Elamin, Daniel R Gomez, Mara B Antonoff, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2019
PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung CancerMarcelo V Negrao, Vincent K Lam, Alexandre Reuben, et al.
Journal of the National Cancer Institute|April 15, 2016
miR-141-Mediated Regulation of Brain Metastasis From Breast CancerBisrat G Debeb, Lara Lacerda, Simone Anfossi, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Plos One|September 10, 2013
The antihelmintic drug pyrvinium pamoate targets aggressive breast cancerWei Xu, Lara Lacerda, Bisrat G Debeb, et al.
Breast Cancer Research and Treatment|November 23, 2015
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3aAdam R Wolfe, Bisrat G Debeb, Lara Lacerda, et al.
Molecular Cancer|July 10, 2010
Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cellsBisrat G Debeb, Xiaomei Zhang, Savitri Krishnamurthy, et al.
Plos One|September 3, 2010
Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cellsAnn H Klopp, Lara Lacerda, Anshul Gupta, et al.
Clinical Lung Cancer|October 22, 2018
Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC)Yasir Y Elamin, Daniel R Gomez, Mara B Antonoff, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2019
PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung CancerMarcelo V Negrao, Vincent K Lam, Alexandre Reuben, et al.
Journal of the National Cancer Institute|April 15, 2016
miR-141-Mediated Regulation of Brain Metastasis From Breast CancerBisrat G Debeb, Lara Lacerda, Simone Anfossi, et al.
Pageof 3